Antibiotic resistance is one of the greatest growing public health threats and a worldwide
priority. According to the WHO, drug-resistant diseases may cause 10 million deaths a year …

As of December 2021, the coronavirus disease 2019 (COVID-19) pandemic has claimed
millions of deaths and caused disruptions in health systems around the world. The short-and …

Coronavirus disease 2019 may have a complex long-term impact on antimicrobial
resistance (AMR). Coordinated strategies at the individual, health-care and policy levels are …

The rapid emergence and spread of antimicrobial resistance continue to kill an estimated
700,000 people annually, and this number is projected to increase ten-fold by 2050. With the …

Before the coronavirus 2019 (COVID-19) pandemic began, antimicrobial resistance (AMR)
was among the top priorities for global public health. Already a complex challenge, AMR …

In recent years, the increase in antimicrobial resistance (AMR) has been recognized as a
real threat to human and animal health. It is a problem that has been given the highest …

The dissemination of COVID-19 around the globe has been followed by an increased
consumption of antibiotics. This is related to the concern for bacterial superinfection in …

Antimicrobial resistance is an urgent threat to public health and global development; in this
scenario, the SARS-CoV2 pandemic has caused a major disruption of healthcare systems …

Antimicrobial resistance (AMR) continues to exert a substantial toll on the global health and
world economy and is now expected to be hidden by COVID-19 for a while. The wrong …

We argue that the COVID-19 pandemic will result in increased antimicrobial resistance
(AMR). Broad-spectrum antibiotic use is common among hospitalized COVID-19 patients …